혹시 love hr(으)로 찾으셨나요?

블로그

• Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer... kinase 4/6 inhibitors (CDK4/6i) have transformed the treatment landscape for hormone receptor-positive (HR However, their long-term efficacy is limited by acquired resistance, and CDK4/6i monotherapy remains blog.naver.com · 2025.08.15